U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 5 Dehydration, CTCAE

MedGen UID:
286554
•Concept ID:
C1559291
•
Finding

Definition

Death [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 5 Dehydration, CTCAE

Recent clinical studies

Etiology

PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Petrylak DP, Vogelzang NJ, Chatta K, Fleming MT, Smith DC, Appleman LJ, Hussain A, Modiano M, Singh P, Tagawa ST, Gore I, McClay EF, Mega AE, Sartor AO, Somer B, Wadlow R, Shore ND, Olson WC, Stambler N, DiPippo VA, Israel RJ
Prostate 2020 Jan;80(1):99-108. Epub 2019 Nov 19 doi: 10.1002/pros.23922. PMID: 31742767
Stereotactic Body Radiotherapy for Elderly Patients With Medically Inoperable Pancreatic Cancer.
Yechieli RL, Robbins JR, Mahan M, Siddiqui F, Ajlouni M
Am J Clin Oncol 2017 Feb;40(1):22-26. doi: 10.1097/COC.0000000000000090. PMID: 24879474

Diagnosis

PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Petrylak DP, Vogelzang NJ, Chatta K, Fleming MT, Smith DC, Appleman LJ, Hussain A, Modiano M, Singh P, Tagawa ST, Gore I, McClay EF, Mega AE, Sartor AO, Somer B, Wadlow R, Shore ND, Olson WC, Stambler N, DiPippo VA, Israel RJ
Prostate 2020 Jan;80(1):99-108. Epub 2019 Nov 19 doi: 10.1002/pros.23922. PMID: 31742767
Stereotactic Body Radiotherapy for Elderly Patients With Medically Inoperable Pancreatic Cancer.
Yechieli RL, Robbins JR, Mahan M, Siddiqui F, Ajlouni M
Am J Clin Oncol 2017 Feb;40(1):22-26. doi: 10.1097/COC.0000000000000090. PMID: 24879474

Therapy

PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Petrylak DP, Vogelzang NJ, Chatta K, Fleming MT, Smith DC, Appleman LJ, Hussain A, Modiano M, Singh P, Tagawa ST, Gore I, McClay EF, Mega AE, Sartor AO, Somer B, Wadlow R, Shore ND, Olson WC, Stambler N, DiPippo VA, Israel RJ
Prostate 2020 Jan;80(1):99-108. Epub 2019 Nov 19 doi: 10.1002/pros.23922. PMID: 31742767

Prognosis

PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Petrylak DP, Vogelzang NJ, Chatta K, Fleming MT, Smith DC, Appleman LJ, Hussain A, Modiano M, Singh P, Tagawa ST, Gore I, McClay EF, Mega AE, Sartor AO, Somer B, Wadlow R, Shore ND, Olson WC, Stambler N, DiPippo VA, Israel RJ
Prostate 2020 Jan;80(1):99-108. Epub 2019 Nov 19 doi: 10.1002/pros.23922. PMID: 31742767

Clinical prediction guides

Stereotactic Body Radiotherapy for Elderly Patients With Medically Inoperable Pancreatic Cancer.
Yechieli RL, Robbins JR, Mahan M, Siddiqui F, Ajlouni M
Am J Clin Oncol 2017 Feb;40(1):22-26. doi: 10.1097/COC.0000000000000090. PMID: 24879474

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...